Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.

Buisman FE, Grünhagen DJ, Homs MYV, Grootscholten C, Filipe WF, Kemeny NE, Cercek A, D'Angelica MI, Donswijk ML, van Doorn L, Emmering J, Jarnagin WR, Kingham TP, Klompenhouwer EG, Kok NFM, Kuiper MC, Moelker A, Prevoo W, Versleijen MWJ, Verhoef C, Kuhlmann KFD, Groot Koerkamp B.

Ann Surg Oncol. 2019 Oct 22. doi: 10.1245/s10434-019-07973-w. [Epub ahead of print]

PMID:
31641947
2.

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.

Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, Schipper L, Hoes L, Vis DJ, van de Haar J, Prevoo W, Snaebjornsson P, van der Velden D, Klein M, Chalabi M, Boot H, van Leerdam M, Bloemendal HJ, Beerepoot LV, Wessels L, Cuppen E, Clevers H, Voest EE.

Sci Transl Med. 2019 Oct 9;11(513). pii: eaay2574. doi: 10.1126/scitranslmed.aay2574.

PMID:
31597751
3.

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B.

BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.

4.

Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BW, Wit EM, Bex A.

Scand J Urol. 2018 Oct - Dec;52(5-6):411-418. doi: 10.1080/21681805.2018.1531057. Epub 2018 Dec 11.

PMID:
30526184
5.

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Kuusk T, Donswijk ML, Valdés Olmos RA, De Bruijn RE, Brouwer OR, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

EJNMMI Res. 2018 Dec 3;8(1):105. doi: 10.1186/s13550-018-0460-y.

6.

Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.

Marquardt S, Kirstein MM, Brüning R, Zeile M, Ferrucci PF, Prevoo W, Radeleff B, Trillaud H, Tselikas L, Vicente E, Wiggermann P, Manns MP, Vogel A, Wacker FK.

Eur Radiol. 2019 Apr;29(4):1882-1892. doi: 10.1007/s00330-018-5729-z. Epub 2018 Sep 25.

PMID:
30255257
7.

Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.

Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, Heymans J, Frankema JS, de Jong KP, Richel DJ, Prevoo W, Vlayen J.

Cardiovasc Intervent Radiol. 2018 Aug;41(8):1189-1204. doi: 10.1007/s00270-018-1959-3. Epub 2018 Apr 17. Review.

8.

Sensitivity and Reproducibility of Automated Feeding Artery Detection Software during Transarterial Chemoembolization of Hepatocellular Carcinoma.

Chiaradia M, Izamis ML, Radaelli A, Prevoo W, Maleux G, Schlachter T, Mayer J, Luciani A, Kobeiter H, Tacher V.

J Vasc Interv Radiol. 2018 Mar;29(3):425-431. doi: 10.1016/j.jvir.2017.10.025. Epub 2018 Feb 3.

PMID:
29402612
9.

Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT Imaging.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, Hendricksen K, Horenblas S, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

J Urol. 2018 Jun;199(6):1426-1432. doi: 10.1016/j.juro.2017.11.112. Epub 2017 Dec 6.

PMID:
29223390
10.

18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.

Samim M, Prevoo W, de Wit-van der Veen BJ, Kuhlmann KF, Ruers T, van Hillegersberg R, van den Bosch MAAJ, Verkooijen HM, Lam MGEH, Stokkel MPM.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1165-1175. doi: 10.1007/s00259-017-3637-0. Epub 2017 Feb 8.

11.

Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma.

Crusz SM, Tang YZ, Sarker SJ, Prevoo W, Kiyani I, Beltran L, Peters J, Sahdev A, Bex A, Powles T, Gerlinger M.

BMC Med. 2016 Nov 14;14(1):185.

12.

In vivo tumor identification of colorectal liver metastases with diffuse reflectance and fluorescence spectroscopy.

Tanis E, Evers DJ, Spliethoff JW, Pully VV, Kuhlmann K, van Coevorden F, Hendriks BH, Sanders J, Prevoo W, Ruers TJ.

Lasers Surg Med. 2016 Nov;48(9):820-827. doi: 10.1002/lsm.22581. Epub 2016 Sep 8.

PMID:
27605447
13.

In vivo characterization of colorectal metastases in human liver using diffuse reflectance spectroscopy: toward guidance in oncological procedures.

Spliethoff JW, de Boer LL, Meier MA, Prevoo W, de Jong J, Kuhlmann K, Bydlon TM, Sterenborg HJ, Hendriks BH, Ruers TJ.

J Biomed Opt. 2016 Sep 1;21(9):97004. doi: 10.1117/1.JBO.21.9.097004.

14.

Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback.

Spliethoff JW, de Boer LL, Meier MAJ, Prevoo W, de Jong J, Bydlon TM, Sterenborg HJCM, Burgers JA, Hendriks BHW, Ruers TJM.

Lung Cancer. 2016 Aug;98:62-68. doi: 10.1016/j.lungcan.2016.05.019. Epub 2016 May 26.

PMID:
27393508
15.

Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma.

de Bruijn RE, Nijkamp J, Noe A, Horenblas S, Haanen JB, Prevoo W, Bex A.

Urol Oncol. 2016 Jun;34(6):258.e7-258.e13. doi: 10.1016/j.urolonc.2015.12.007. Epub 2016 Jan 25.

PMID:
26822077
16.

Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy.

Tanis E, Spliethoff JW, Evers DJ, Langhout GC, Snaebjornsson P, Prevoo W, Hendriks BH, Ruers TJ.

Eur J Surg Oncol. 2016 Feb;42(2):251-9. doi: 10.1016/j.ejso.2015.12.005. Epub 2015 Dec 23.

PMID:
26746090
17.

Real-time In Vivo Tissue Characterization with Diffuse Reflectance Spectroscopy during Transthoracic Lung Biopsy: A Clinical Feasibility Study.

Spliethoff JW, Prevoo W, Meier MA, de Jong J, Klomp HM, Evers DJ, Sterenborg HJ, Lucassen GW, Hendriks BH, Ruers TJ.

Clin Cancer Res. 2016 Jan 15;22(2):357-65. doi: 10.1158/1078-0432.CCR-15-0807. Epub 2015 Aug 31.

18.

[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.

Samim M, El-Haddad GE, Molenaar IQ, Prevoo W, van den Bosch MA, Alavi A, Lam MG.

PET Clin. 2014 Oct;9(4):469-95, vi. doi: 10.1016/j.cpet.2014.07.004. Epub 2014 Aug 12. Review.

PMID:
26050948
19.

Diffuse reflectance spectroscopy: toward real-time quantification of steatosis in liver.

Evers DJ, Westerkamp AC, Spliethoff JW, Pully VV, Hompes D, Hendriks BH, Prevoo W, van Velthuysen ML, Porte RJ, Ruers TJ.

Transpl Int. 2015 Apr;28(4):465-74. doi: 10.1111/tri.12517. Epub 2015 Jan 21.

20.

Monitoring of tumor radio frequency ablation using derivative spectroscopy.

Spliethoff JW, Tanis E, Evers DJ, Hendriks BH, Prevoo W, Ruers TJ.

J Biomed Opt. 2014 Sep;19(9):97004. doi: 10.1117/1.JBO.19.9.097004.

21.

A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer.

Hompes D, Aalbers A, Boot H, van Velthuysen ML, Vogel W, Prevoo W, van Tinteren H, Verwaal V.

Colorectal Dis. 2014 Aug;16(8):O264-72. doi: 10.1111/codi.12560.

PMID:
24433532
22.

Can previous diagnostic examinations prevent preoperative angiographic assessment of the internal mammary perforators for (micro)surgical use?

Schellekens PP, Aukema TS, Hage JJ, Prevoo W, Kon M.

Ann Plast Surg. 2014 May;72(5):560-5. doi: 10.1097/SAP.0b013e318268a896.

PMID:
23486113
23.

Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation.

Kroon BK, de Bruijn R, Prevoo W, Horenblas S, Powles T, Bex A.

Urology. 2013 Jan;81(1):111-5. doi: 10.1016/j.urology.2012.09.014. Epub 2012 Nov 13. Review.

PMID:
23153934
24.

Local treatment of pulmonary metastases: from open resection to minimally invasive approach? Less morbidity, comparable local control.

von Meyenfeldt EM, Wouters MW, Fat NL, Prevoo W, Burgers SA, van Sandick JW, Klomp HM.

Surg Endosc. 2012 Aug;26(8):2312-21. doi: 10.1007/s00464-012-2181-z. Epub 2012 Feb 21.

PMID:
22350235
25.

Percutaneous radiofrequency ablation of a small renal mass complicated by appendiceal perforation.

Boone J, Bex A, Prevoo W.

Cardiovasc Intervent Radiol. 2012 Jun;35(3):695-9. doi: 10.1007/s00270-011-0281-0. Epub 2011 Oct 20.

26.

Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.

Hompes D, Prevoo W, Ruers T.

Cancer Imaging. 2011 Mar 24;11:23-30. doi: 10.1102/1470-7330.2011.0004. Review.

27.

Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours.

Korse CM, Bonfrer JM, Prevoo W, Baas P, Taal BG.

Tumour Biol. 2011 Aug;32(4):647-52. doi: 10.1007/s13277-011-0164-7. Epub 2011 Mar 5.

PMID:
21373992
28.

Local progression after radiofrequency ablation for pulmonary metastases.

von Meyenfeldt EM, Prevoo W, Peyrot D, Lai A Fat N, Burgers SJ, Wouters MW, Klomp HM.

Cancer. 2011 Aug 15;117(16):3781-7. doi: 10.1002/cncr.25958. Epub 2011 Feb 11.

29.

Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients.

Bex A, Vermeeren L, Meinhardt W, Prevoo W, Horenblas S, Valdés Olmos RA.

World J Urol. 2011 Dec;29(6):793-9. doi: 10.1007/s00345-010-0615-6. Epub 2010 Nov 25.

PMID:
21107845
30.

Radiofrequency ablation of kidney tumours in patients with a solitary kidney.

Prevoo W, van den Munckhof MP, Meinhardt W, Horenblas S, van den Bosch MA.

Clin Radiol. 2010 Mar;65(3):230-6. doi: 10.1016/j.crad.2009.11.007. Epub 2010 Jan 15. No abstract available.

PMID:
20152280
31.

Feasibility of sentinel node detection in renal cell carcinoma: a pilot study.

Bex A, Vermeeren L, de Windt G, Prevoo W, Horenblas S, Olmos RA.

Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1117-23. doi: 10.1007/s00259-009-1359-7. Epub 2010 Jan 29.

PMID:
20111964
32.

[The radiologist as the treating physician for cancer: interventional oncology].

van den Bosch MA, Prevoo W, van der Linden EM, Meijerink MR, van Delden OM, Mali WP, Reekers JA.

Ned Tijdschr Geneeskd. 2009;153:A532. Review. Dutch.

PMID:
19785894
33.

Adhesive arachnoiditis following percutaneous cervical cordotomy--may we still use lipiodol?

Lukas A, van der Weide M, Boogerd W, Prevoo W, Zuurmond WW, Sanders M.

J Pain Symptom Manage. 2008 Nov;36(5):e1-4. doi: 10.1016/j.jpainsymman.2008.07.003. Epub 2008 Sep 26. No abstract available.

PMID:
18823752
34.

[Guideline 'Renal cell carcinoma'].

Prevoo W, van den Bosch MA, Horenblas S.

Ned Tijdschr Geneeskd. 2008 Jun 7;152(23):1350; author reply 1350. Dutch. No abstract available.

PMID:
18661865
35.

Radiofrequency ablation for treatment of sporadic angiomyolipoma.

Prevoo W, van den Bosch MA, Horenblas S.

Urology. 2008 Jul;72(1):188-91. doi: 10.1016/j.urology.2008.02.059. Epub 2008 May 2.

PMID:
18455777
36.

Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors.

Jansen MC, van Wanrooy S, van Hillegersberg R, Rijken AM, van Coevorden F, Prevoo W, van Gulik TM.

Eur J Surg Oncol. 2008 Jun;34(6):662-7. Epub 2007 Sep 24.

PMID:
17892922
37.

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation.

Meij V, Zuetenhorst JM, van Hillegersberg R, Kröger R, Prevoo W, van Coevorden F, Taal BG.

World J Surg Oncol. 2005 Nov 17;3:75.

38.

Adverse effects of radiofrequency ablation of liver tumours in the Netherlands.

Jansen MC, van Duijnhoven FH, van Hillegersberg R, Rijken A, van Coevorden F, van der Sijp J, Prevoo W, van Gulik TM.

Br J Surg. 2005 Oct;92(10):1248-54.

PMID:
15997440
39.

Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.

Vermeulen EG, Stehouwer CD, Valk J, van der Knaap M, van den Berg M, Twisk JW, Prevoo W, Rauwerda JA.

Eur J Clin Invest. 2004 Apr;34(4):256-61.

PMID:
15086356
40.

The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers.

Kaas R, Kroger R, Hendriks JH, Besnard AP, Koops W, Pameijer FA, Prevoo W, Loo CE, Muller SH.

Eur Radiol. 2004 Sep;14(9):1647-53. Epub 2004 Apr 9.

PMID:
15083333
41.

Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands.

Mutsaerts EL, Van Coevorden F, Krause R, Borel Rinkes IH, Strobbe LJ, Prevoo W, Tollenaar RA, van Gulik TM.

Eur J Surg Oncol. 2003 Nov;29(9):731-4.

PMID:
14602491
42.

Technical considerations in laparoscopic liver surgery.

Berends FJ, Meijer S, Prevoo W, Bonjer HJ, Cuesta MA.

Surg Endosc. 2001 Aug;15(8):794-8. Epub 2001 Jun 12.

PMID:
11443467
43.

Macrophage populations in different stages of induced hepatic metastases in rats: an immunohistochemical analysis.

Heuff G, van der Ende MB, Boutkan H, Prevoo W, Bayon LG, Fleuren GJ, Beelen RH, Meijer S, Dijkstra CD.

Scand J Immunol. 1993 Jul;38(1):10-6.

PMID:
8327856
44.

The impact of intraoperative ultrasonography of the liver on the surgical strategy of patients with gastrointestinal malignancies and hepatic metastases.

Boutkan H, Luth W, Meyer S, Cuesta M, van Heuzen E, Prevoo W.

Eur J Surg Oncol. 1992 Aug;18(4):342-6.

PMID:
1521627
45.

Intra-operative ultrasonography of the liver: a prerequisite for surgery of colorectal cancer?

Boutkan H, Meijer S, Cuesta MA, Prevoo W, Luth WJ, Van Heuzen EP.

Neth J Surg. 1991 Aug;43(4):89-91.

PMID:
1944995

Supplemental Content

Loading ...
Support Center